awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q40678981-0F6CAA20-8EEA-4561-8BCC-CAAC920E8F88
Q40678981-0F6CAA20-8EEA-4561-8BCC-CAAC920E8F88
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40678981-0F6CAA20-8EEA-4561-8BCC-CAAC920E8F88
Anti-Neoplastic Cytotoxicity of Gemcitabine-(C4-amide)-[anti-HER2/neu] in Combination with Griseofulvin against Chemotherapeutic-Resistant Mammary Adenocarcinoma (SKBr-3).
P2860
Q40678981-0F6CAA20-8EEA-4561-8BCC-CAAC920E8F88
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40678981-0F6CAA20-8EEA-4561-8BCC-CAAC920E8F88
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
efb88f7537c6ab22569caf9bc1e874be7137f2dc
P2860
Anti-Neoplastic Cytotoxicity of Gemcitabine-(C4-amide)-[anti-EGFR] in Dual-combination with Epirubicin-(C3-amide)-[anti-HER2/neu] against Chemotherapeutic-Resistant Mammary Adenocarcinoma (SKBr-3) and the Complementary Effect of Mebendazole.